Ueda R - Search Results

1

Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.

Niwa R, Sakurada M, Kobayashi Y, Uehara A, Matsushima K, Ueda R, Nakamura K, Shitara K. Niwa R, et al. Among authors: ueda r. Clin Cancer Res. 2005 Mar 15;11(6):2327-36. doi: 10.1158/1078-0432.CCR-04-2263. Clin Cancer Res. 2005. PMID: 15788684

2

Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma.

Niwa R, Shoji-Hosaka E, Sakurada M, Shinkawa T, Uchida K, Nakamura K, Matsushima K, Ueda R, Hanai N, Shitara K. Niwa R, et al. Among authors: ueda r. Cancer Res. 2004 Mar 15;64(6):2127-33. doi: 10.1158/0008-5472.can-03-2068. Cancer Res. 2004. PMID: 15026353

3

Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma.

Ishii T, Ishida T, Utsunomiya A, Inagaki A, Yano H, Komatsu H, Iida S, Imada K, Uchiyama T, Akinaga S, Shitara K, Ueda R. Ishii T, et al. Among authors: ueda r. Clin Cancer Res. 2010 Mar 1;16(5):1520-31. doi: 10.1158/1078-0432.CCR-09-2697. Epub 2010 Feb 16. Clin Cancer Res. 2010. PMID: 20160057

4

The therapeutic potential of a novel PSMA antibody and its IL-2 conjugate in prostate cancer.

Sugimoto Y, Hirota M, Yoshikawa K, Sumitomo M, Nakamura K, Ueda R, Niwa R, Suzawa T, Yamasaki M, Shitara K, Kato T, Nakamura K. Sugimoto Y, et al. Among authors: ueda r. Anticancer Res. 2014 Jan;34(1):89-97. Anticancer Res. 2014. PMID: 24403448

5

The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma.

Ishida T, Iida S, Akatsuka Y, Ishii T, Miyazaki M, Komatsu H, Inagaki H, Okada N, Fujita T, Shitara K, Akinaga S, Takahashi T, Utsunomiya A, Ueda R. Ishida T, et al. Among authors: ueda r. Clin Cancer Res. 2004 Nov 15;10(22):7529-39. doi: 10.1158/1078-0432.CCR-04-0983. Clin Cancer Res. 2004. PMID: 15569983

6

Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.

Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, Kusumoto S, Takeuchi G, Shimizu S, Ito M, Komatsu H, Wakita A, Eimoto T, Matsushima K, Ueda R. Ishida T, et al. Among authors: ueda r. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3625-34. Clin Cancer Res. 2003. PMID: 14506150

7

Further investigation of the epitope recognized by the new monoclonal antibody 2C9.

Kato K, Yoshikawa K, Taki T, Shitara K, Nakamura K, Hirota M, Hanai N, Nakamura K, Kokubo H, Mitsui K, Yamada Y, Honda N, Ueda R, Saga S, Fukatsu H. Kato K, et al. Among authors: ueda r. Int J Urol. 2003 Aug;10(8):439-44. doi: 10.1046/j.1442-2042.2003.00655.x. Int J Urol. 2003. PMID: 12887366 Free article.

8

Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.

Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K, Nakamura S, Inagaki H, Ohshima K, Kiyoi H, Ishida T, Matsushima K, Akinaga S, Ogura M, Tomonaga M, Ueda R. Yamamoto K, et al. Among authors: ueda r. J Clin Oncol. 2010 Mar 20;28(9):1591-8. doi: 10.1200/JCO.2009.25.3575. Epub 2010 Feb 22. J Clin Oncol. 2010. PMID: 20177026 Clinical Trial.

9

Defucosylated anti CC chemokine receptor 4 monoclonal antibody combined with immunomodulatory cytokines: a novel immunotherapy for aggressive/refractory Mycosis fungoides and Sezary syndrome.

Yano H, Ishida T, Inagaki A, Ishii T, Ding J, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R. Yano H, et al. Among authors: ueda r. Clin Cancer Res. 2007 Nov 1;13(21):6494-500. doi: 10.1158/1078-0432.CCR-07-1324. Clin Cancer Res. 2007. PMID: 17975162

10

CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified.

Ishida T, Inagaki H, Utsunomiya A, Takatsuka Y, Komatsu H, Iida S, Takeuchi G, Eimoto T, Nakamura S, Ueda R. Ishida T, et al. Among authors: ueda r. Clin Cancer Res. 2004 Aug 15;10(16):5494-500. doi: 10.1158/1078-0432.CCR-04-0371. Clin Cancer Res. 2004. PMID: 15328188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,097 results

Search Page